| dc.contributor.author |
Plastiras, D |
en |
| dc.contributor.author |
Moutzouris, G |
en |
| dc.contributor.author |
Barbatis, C |
en |
| dc.contributor.author |
Presvelos, V |
en |
| dc.contributor.author |
Petrakos, M |
en |
| dc.contributor.author |
Theodorou, C |
en |
| dc.date.accessioned |
2014-06-06T06:43:51Z |
|
| dc.date.available |
2014-06-06T06:43:51Z |
|
| dc.date.issued |
1999 |
en |
| dc.identifier.uri |
http://dx.doi.org/10.1053/ejso.1998.0601 |
en |
| dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/1507 |
|
| dc.subject |
Bladder Cancer |
en |
| dc.subject |
Life Expectancy |
en |
| dc.subject |
Patient Survival |
en |
| dc.subject |
Prognostic Factor |
en |
| dc.subject |
Statistical Analysis |
en |
| dc.subject |
High Risk |
en |
| dc.title |
Can p53 nuclear over-expression, Bcl2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours? |
en |
| heal.type |
journalArticle |
en |
| heal.identifier.primary |
10.1053/ejso.1998.0601 |
en |
| heal.publicationDate |
1999 |
en |
| heal.abstract |
AimsTo evaluate p53 and Bcl-2 expression and proliferating status (PCNA) in subgroups of patients with high-risk superficial and invasive bladder cancer, with relation to cancer progression and death, and to correlate the results with established clinical prognostic factors.MethodsParaffin-embedded sections from 42 high-risk superficial (T1G2,T1G3) and 33 invasive (T2–T4aG3N0M0) tumours were investigated immunohistochemically for p53, Bcl-2 and PCNA. The median follow-up |
en |
| heal.journalName |
Ejso |
en |
| dc.identifier.doi |
10.1053/ejso.1998.0601 |
en |